ProPhase Labs, a biotech firm exploring a crypto treasury strategy, has placed its three units under Chapter 11 bankruptcy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback